http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 MUKILTEO, Wash., Jun 3, 2009 -- CombiMatrix Corporation (Nasdaq:CBMX) today announced that the validation study performed by its wholly owned subsidiary, Combimatrix Molecular Diagnostics (CMDX), in... http://pharmalicensing.com/redirs/news_rss//public/news/view/483421/1/0/combimatrix-publishes-clinical-study-of-its-herscan-tm-breast-cancer-test http://pharmalicensing.com/redirs/news_rss//public/news/view/483421/1/0/combimatrix-publishes-clinical-study-of-its-herscan-tm-breast-cancer-test Pompey, France, July 2, 2009 - Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announces today the acquisition... http://pharmalicensing.com/redirs/news_rss//public/news/view/483394/1/0/novasep-acquires-bioprocess-development-specialist-and-contract-manufacturer-henogen http://pharmalicensing.com/redirs/news_rss//public/news/view/483394/1/0/novasep-acquires-bioprocess-development-specialist-and-contract-manufacturer-henogen SALT LAKE CITY, July 1, 2009 -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today the successful completion of the spin off of Myriad Pharmaceuticals, Inc. (Nasdaq:MYRX), and that Myriad Genetics... http://pharmalicensing.com/redirs/news_rss//public/news/view/483339/1/0/myriad-genetics-announces-completion-of-spin-off-of-its-research-and-pharmaceutical-business http://pharmalicensing.com/redirs/news_rss//public/news/view/483339/1/0/myriad-genetics-announces-completion-of-spin-off-of-its-research-and-pharmaceutical-business July 1st, 2009--A novel automated solution developed through a collaboration between Tecan and researchers at the Zurich University of Applied Sciences in W http://pharmalicensing.com/redirs/news_rss//public/news/view/483351/1/0/cti-medtech-award-nomination-for-automated-quality-controlled-cell-culturing-system http://pharmalicensing.com/redirs/news_rss//public/news/view/483351/1/0/cti-medtech-award-nomination-for-automated-quality-controlled-cell-culturing-system BURLINGTON, N.C -- July 1, 2009-- Laboratory Corporation of America http://pharmalicensing.com/redirs/news_rss//public/news/view/483365/1/0/labcorp-commences-cash-tender-offer-for-all-outstanding-shares-of-monogram-biosciences-inc http://pharmalicensing.com/redirs/news_rss//public/news/view/483365/1/0/labcorp-commences-cash-tender-offer-for-all-outstanding-shares-of-monogram-biosciences-inc Raleigh, NC, July 1, 2009 - INC Research http://pharmalicensing.com/redirs/news_rss//public/news/view/483372/1/0/inc-research-completes-acquisition-of-global-clinical-development-unit-of-mds-pharma-services http://pharmalicensing.com/redirs/news_rss//public/news/view/483372/1/0/inc-research-completes-acquisition-of-global-clinical-development-unit-of-mds-pharma-services CAMBRIDGE, Ma. & HAWTHORNE, N.Y.--Jul. 1, 2009-- Biogen Idec (NASDAQ:BIIB) and Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that they have entered into an exclusive collaboration and... http://pharmalicensing.com/redirs/news_rss//public/news/view/483423/1/0/biogen-idec-and-acorda-therapeutics-announce-collaboration-agreement-to-develop-and-commercialize-ms-therapy-fampridine-sr-in-markets-outside-the-u-s http://pharmalicensing.com/redirs/news_rss//public/news/view/483423/1/0/biogen-idec-and-acorda-therapeutics-announce-collaboration-agreement-to-develop-and-commercialize-ms-therapy-fampridine-sr-in-markets-outside-the-u-s July 01, 2009 - The National Science Foundation has awarded a Phase I Small Business Innovation Research (SBIR) grant to life science tools company GWC Technologies. The grant will accelerate... http://pharmalicensing.com/redirs/news_rss//public/news/view/483223/1/0/gwc-technologies-awarded-nsf-grant-to-develop-protein-arrays http://pharmalicensing.com/redirs/news_rss//public/news/view/483223/1/0/gwc-technologies-awarded-nsf-grant-to-develop-protein-arrays June 30, 2009 Deltex Medical Group plc ("Deltex Medical" or the "Company"), was notified today that certain of its current employees have acquired 675,553 ordinary shares of 1p each as the result of... http://pharmalicensing.com/redirs/news_rss//public/news/view/483356/1/0/exercise-of-options-and-additional-listing http://pharmalicensing.com/redirs/news_rss//public/news/view/483356/1/0/exercise-of-options-and-additional-listing REDWOOD CITY, Calif., June 30, 2009 - Maxygen, Inc. (Nasdaq: MAXY) today announced that Astellas Pharma Inc. and Maxygen have executed an agreement to establish a joint venture focused on the... http://pharmalicensing.com/redirs/news_rss//public/news/view/483361/1/0/maxygen-announces-joint-venture-with-astellas-to-develop-protein-pharmaceuticals http://pharmalicensing.com/redirs/news_rss//public/news/view/483361/1/0/maxygen-announces-joint-venture-with-astellas-to-develop-protein-pharmaceuticals